Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Thyroid Neoplasms 8Carcinoma, Medullary 6Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 3Thyroid Cancer, Papillary 2Familial medullary thyroid carcinoma 2Adenocarcinoma, Follicular 2Thyroid cancer, medullary 1Thyroid Diseases 1Thyroid Carcinoma, Anaplastic 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Neoplasms 1Neoplasm Metastasis 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Locally Advanced Thyroid Gland Carcinoma 1Esthesioneuroblastoma, Olfactory 1Differentiated Thyroid Cancer 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cisplatin 5Platinum 4Cetuximab 41,2-diaminocyclohexaneplatinum II citrate 4Carboplatin 3Radiotherapy, Intensity-Modulated 2Nivolumab 2Immunoglobulin G 2Gemcitabine 2Gefitinib 2Fluorouracil 2Docetaxel 2Disulfides 2Biopsy 2Bevacizumab 2vandetanib 1temsirolimus 1linrodostat 1ficlatuzumab 1durvalumab 1dl1520 1dehydroftorafur 1cediranib 1atezolizumab 1adavosertib 1X-Rays 1Trioxsalen 1Specimen Handling 1Soybean Proteins 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoid Interstitial Pneumonia × vandetanib × Head & Neck × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡